Top Markets
Coin of the day
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
Kedudukan dalam Saham #25715
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Harga Saham
$1.45
Disegerakkan terakhir: 2026-08-19
Modal Pasaran
$46.94M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-18.08%
Negara
US
Perdagangan Vicapsys Life Sciences, Inc. (VICP)

Kategori

Sejarah pecahan saham untuk Vicapsys Life Sciences, Inc. (VICP)
Saham Vicapsys Life Sciences, Inc. (simbol: VICP) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 21, 2026.
Satu saham VICP yang dibeli sebelum Aug 21, 2026 kini bersamaan dengan 0 saham VICP.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US